NextGen Sciences this week launched its csfdiscovery 82 multiplex protein assay for the discovery and quantification of protein biomarkers linked to central nervous system diseases including Alzheimer's, Parkinson's, and multiple sclerosis.
The assay uses multiple-reaction monitoring mass spectrometry to simultaneously measure 82 proteins in cerebrospinal fluid samples.